origin therapeutics

This Week in Psychedelics - 12.3.21

Cannabis

  • Home of Dubai, the United Arab Emirates, Ends Jail Time for Travelers with THC (High Times)

  • Mexico has a new marijuana legalization bill. Here’s what’s in it (Leafly)

  • Reps. Dave Joyce and Alexandria Ocasio-Cortez Introduce Legislation To Expunge Marijuana Records (NORML)

  • South Dakota's Governor Succeeds in Blocking Voter-Approved Marijuana Legalization (Reason)

  • Fentanyl-laced vape pens among teens concern after Tennessee high school incident (WKYT)

  • Record Number of Scientific Papers Published About Cannabis in 2021 (NORML)

  • Death sentences upheld for two men convicted of cannabis trafficking (Singapore Law Watch)

  • California rolls out plans to standardize cannabis testing statewide (Marijuana Business Daily)

  • Jamaican Government Launches ‘Good Ganja Sense’ Campaign To Debunk Marijuana Myths (Marijuana Moment)

  • Great News, Scientists Finally Figured Out Why Cannabis Smells 'Skunky' (ScienceAlert)

  • Texas Activists Turn In Signatures To Put Marijuana Decriminalization On Austin’s 2022 Ballot (Marijuana Moment)

  • Kentucky Lawmaker Pre-Files Marijuana Legalization Bills For 2022 Session (Marijuana Moment)

  • Colorado University Announces Groundbreaking Study on Cannabis and Exercise (High Times)

  • Massachusetts: Majority of Adults Say Marijuana Legalization Has Been “Positive” for the State (NORML)

LSD

  • Blotter paper should be included while measuring weight of LSD, rules Bombay HC (India Today)

  • How LSD changed The Beatles forever (Far Out Magazine)

Magic Mushrooms

  • New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression (Psychedelic Spotlight)

  • Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress (Psilocybin Alpha)

  • U of M Medical School launches new mechanistic study of psilocybin (University of Minnesota)

Ayahuasca

  • Sexual Assault in the Amazon (The Cut)

Iboga

Novel Psychoactive Substances

  • MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation (Psilocybin Alpha)

  • Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases (Psilocybin Alpha)

Nitrous Oxide

  • ‘Everyone’s gagging for it’ – how Britain got high on nitrous oxide (The Guardian)

  • Dozens of traffic accident deaths linked to laughing gas use (NL Times)

Ketamine

  • Ketamine review: Chemical restraints may have been ‘disproportionately’ used on ‘communities of color’ (KDVR)

  • As ketamine clinics emerge in Seattle to treat mental illness, so does debate about safety and regulations (The Seattle Times)

  • PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio (Psilocybin Alpha)

Miscellaneous

  • New York City Opens First Safe Consumption Sites For Illegal Drugs In The U.S. (Marijuana Moment)

  • Florida Lawmaker Files Bill To Decriminalize All Currently Illicit Drugs (Marijuana Moment)

  • Toronto May Be the Next City to Decriminalize Psychedelics and Other Drugs (Truffle Report)

  • Study Shows People Who Use Psychedelics Were Under Less Stress During Covid-19 Lockdowns (Forbes)

  • DEA Again Boosts 2022 Production Goals For Psychedelics Like Psilocybin, MDMA and DMT (Marijuana Moment)

  • People ‘microdosing’ psychedelics to improve wellbeing during pandemic, drug survey finds (The Independent)

  • Psychedelics may have long-term impact treating depression, mental illness - study (The Jerusalem Post)

  • Psychedelic Telemedicine Has Arrived. What Could Possibly Go Wrong? (VICE)

  • The Psychedelic Renaissance Is Ushering In a New Genre Of Electronic Music — And With It, New Revenue Streams (Billboard)

  • Holiday Gift Guide 2021: Gifts For The Psychedelic Explorer (Forbes)

  • Can ethics and sexual abuse allegations create backlash and impact the current psychedelic renaissance? (Chacruna)

  • Will the psychedelic revolution bypass people of color? (The Lens)

  • Celebrities: Are They Helping or Harming the Psychedelic Movement? (Psychedelic Spotlight)

  • Origin Therapeutics Portfolio Company Tripsitter has Commenced Trading on the Canadian Securities Exchange (GlobeNewswire)

  • Peter Thiel-backed psychedelic start-up increases stake in Compass Pathways (CNBC)

  • Microdosing Protocols: Microdosing Every Day vs. Every Other Day (DoubleBlind)

  • Editor’s Choice Award 2021-Best Study on Psychedelics and Neurochemistry (Psychedelic Science Review)

  • Novel Psychedelic Treatment Approach Bypasses Hallucinogenic Effects to Allow Widespread Adoption (Pharmacy Times)

  • Israeli start up makes pharmaceuticals out of psychedelic flora (i24 News)

  • Getting Ahead of the Psychedelics Supply Crunch (Truffle Report)

  • Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.